Join global research on Alzheimer’s disease!

Your participation and support can help us find ways to diagnose, treat and prevent inherited and other forms of Alzheimer’s disease.

Join the Registry

DIAN Expanded Registry

Our global registry allows families to learn about research and educational opportunities and helps scientists find out how to get involved in research.
Clinical Trials

Drug trials are available for individuals who have or are at risk for dominantly inherited Alzheimer's disease.
Observational Study

By observing participants over time, our Observational Study aims to learn how Alzheimer's disease progresses and find ways to treat and prevent the disease.

What is Dominantly Inherited Alzheimer's?

DIAD is a rare form of Alzheimer’s disease (AD) that causes memory loss and dementia in people typically in their 30s to 50s. The disease affects less than 1% of the total population.

Hearts and minds seek Alzheimer's solutions

Meet the families and researchers who are partnering to conduct groundbreaking research to find effective therapies for Alzheimer’s.

News

Mar 9, 2022

Could drugs prevent Alzheimer’s? These trials aim to find out

Nature - Mar 9, 2022

Feb 23, 2022

Blood test for Alzheimer’s highly accurate in large, international study

The Source, Washington University in St. Louis - Feb 22, 2022

Jan 19, 2022

First Subject Enrolled in Phase II/III Study of Eisai’s Anti-MTBR Tau Antibody E2814 for Dominantly Inherited Alzheimer’s Disease (DIAD), conducted by DIAN-TU

Eisai Co., Ltd. - Jan 19 2022

More News